Additional pharmacodynamic data supports inhibition of PLK1 in leukemic cells as measured by pTCTP in its Phase 1b/2 trial in Acute Myeloid Leukemia (AML)
PR Newswire
SAN DIEGO, June 27, 2018
PR Newswire
SAN DIEGO, June 27, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey